Immucell Corp Stock
Your prediction
Immucell Corp Stock
A very strong showing by Immucell Corp today, with an increase of €0.35 (6.670%) compared to yesterday's price.
Pros and Cons of Immucell Corp in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | 6.670% | 8.738% | 13.821% | 13.821% | 9.804% | -14.504% | 10.891% |
| Vaxart Inc. | 46.340% | 50.735% | 45.390% | -45.333% | 46.429% | -57.914% | -92.039% |
| Larimar Therapeutics Inc. | -2.110% | -3.425% | -14.024% | -19.429% | -15.060% | -31.220% | -81.923% |
| aTyr Pharma Inc | -23.530% | -7.965% | -12.605% | -85.556% | -13.333% | -75.060% | -84.524% |
News
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company